The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Louis Pasteur devised the first vaccines for humans, an anti-rabies vaccine, saving millions of lives by prevention of disease. He also developed vaccines for animal health, helping the industry get off the ground. Nowadays, companies have access to many discoveries made at the Institut Pasteur. Several have resulted in major products that contributed to improve human health, such as the Hepatitis B vaccine.
Use of measlesvirus to produce recombinant or chimeric replicative vaccines
Therapeutic vaccine against HBV-infected hepatocytes
Versatile delivery system for antigens or biologically active molecules
MUC6-Tn glycoconjugates mimicking cancer cells: applications to anti-tumor immunotherapy
Infectious chimeric GB virus B containing the core domain III of the Hepatitis C virus (HCV) IRES that is infectious and causes hepatitis in tamarins: a new animal model for HCV studies
Identification of independant folder domains of the alphavirus glycoprotein E2 antigenic determinants of the virus, and generation of constructs for their recombinant production as potent immunogens
Isolation of neutralizing monoclonal antibodies against the Chikungunya virus
Vaccine against Yersinia pestis
Broadly neutralizing anti-HCV E2 llama antibody and its derivatives
A highly attenuated Mycobacterium tuberculosis EXX-5 PE-1 PPE deletion mutant confers potent protective immunity against tuberculosis